What is the iCMLf?

The iCMLf is a Foundation established by a group of hematologists with a strong interest in CML. 
Our mission is to improve the outcomes for patients with CML globally. We are currently registered as a charitable foundation in England and Wales but our charter is global.

What are our aims and priorities?

The aims of the International CML Foundation (iCMLf) are to foster and coordinate global clinical and research collaborations and to improve clinical practice and disease monitoring in CML. There are numerous activities that could come within this broad charter but the initial focus is to meet the needs in CML that are not already being met by other groups, particularly those needs that are best met by a global organization.

What are our guiding principles?

How is the iCMLf governed and financed?

The iCMLf has

The iCMLf was co-sponsor of the International Meeting on CML with  the European School of Hematology held in Bordeaux, September 11-13 2009, and will provide scientific leadership for future annual meetings (eg in Washington DC in September 2010)

>> Link to the conference's programme

Donate in John's memory    

A special thank you to those who have already donated to the John Goldman fund. It's thanks to your contribution that the John Goldman fund comes to life supporting young physicians from the emerging regions. 

To donate to the iCMLf John Goldman fund click here

Dr Adeagbo Babatunde, PhD

(Ile-Ife, Nigeria)

'It was an honour for me to present my data at this well-known conference on CML and to discuss the results with the international CML community. It was also a great chance for me to network with people from around the world and a great experience for me to listen to some of the most renowned leaders in the field of CML during the scientific sessions at the meeting.' 
(Dr Babatunde, Nigeria)

Dr Babatunde was supported by the John Goldman Fund in 2015 to attend the John Goldman Conference on CML in Estoril. He presented his poster on ‘Pharmacokinetics on imatinib in Nigerians’ with CML during the interactive poster walks on the biology of CML.

You can read his full abstract here

Read more

Dr Carolina Pavlovsky, MD

Fundaleu Hospital and Clinical Research Center

Buenos Aires, Argentina

Carolina Pavlovsky works as a hematologist at Fundaleu (Foundation to fight Leukemia) in Buenos Aires and serves as Head of the Research Department since 2010. She received her doctorate from the University of Buenos Aires and completed her training in internal medicine and hematology at the National Academy of Medicine in Buenos Aires.

Her main interests are chronic leukemias: molecular and clinical aspects. Since 2003, she has worked on multiple research protocols for chronic leukemias and is in charge of CML and CLL projects. Since 2005, she has coordinated an Argentine multi-center study on molecular monitoring in patients with CML and since 2011 she coordinates the clinical aspects of a new multi-centric study on mutational analysis of patients with CML and treatment failure. In June 2008, she undertook a training at the Department of Leukemias at the MD Anderson Cancer Center in Houston. In 2014 she obtained a Master's degree in Molecular Oncology from the National Cancer Research Center of Spain (CNIO) and the European School of Oncology (ESO).